Waystar Holding Corp. (Nasdaq: WAY), a prominent provider of healthcare payment software, has announced a successful repricing of its first lien term loan, originally due in October 2029. The company has secured more favorable terms with a reduced interest rate of adjusted SOFR +2.00%, marking a 25-basis-point reduction from previous terms. This move comes amid strong demand from both new and existing lenders, highlighting confidence in Waystar's solid financial standing and cash flow generation. Additionally, Waystar will incorporate $250 million in incremental term loans under the same terms, contingent upon the closing of the Iodine Software acquisition. This strategic financial adjustment aims to support Waystar's growth strategy and competitive edge, with reassurances from S&P, Moody's, and Fitch, who have reaffirmed the company's debt rating and stable outlook.